Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 160,268 | 134,216 | 119,126 | 128,308 | 117,206 |
| Cost of Goods | 32,296 | 25,008 | 20,780 | 26,885 | 22,959 |
| Gross Profit | 127,972 | 109,208 | 98,346 | 101,423 | 94,247 |
| Operating Expenses | 63,759 | 62,314 | 58,703 | 54,695 | 83,305 |
| Operating Income | 64,509 | 46,902 | 40,423 | 47,613 | 11,901 |
| Interest Expense | 7,012 | 6,218 | 5,731 | 6,709 | 3,990 |
| Other Income | -5,665 | 3,411 | 3,088 | 3,199 | 56 |
| Pre-tax Income | 51,832 | 44,095 | 37,780 | 44,103 | 7,967 |
| Income Tax | 13,371 | 9,795 | 8,295 | -4,406 | -79,976 |
| Net Income Continuous | 38,461 | 34,300 | 29,485 | 48,509 | 87,943 |
| Net Income | $38,461 | $34,300 | $29,485 | $48,509 | $87,943 |
| EPS Basic Total Ops | 0.64 | 0.57 | 0.49 | 0.83 | 1.48 |
| EPS Basic Continuous Ops | 0.64 | 0.57 | 0.49 | 0.82 | 1.48 |
| EPS Diluted Total Ops | 0.63 | 0.56 | 0.48 | 0.79 | 1.44 |
| EPS Diluted Continuous Ops | 0.63 | 0.56 | 0.48 | 0.79 | 1.44 |
| EBITDA(a) | $71,145 | $52,714 | $46,267 | $53,671 | $18,382 |